121 related articles for article (PubMed ID: 27163153)
1. Predicting Lymph Node Metastasis in Endometrial Cancer Using Serum CA125 Combined with Immunohistochemical Markers PR and Ki67, and a Comparison with Other Prediction Models.
Yang B; Shan B; Xue X; Wang H; Shan W; Ning C; Zhou Q; Chen X; Luo X
PLoS One; 2016; 11(5):e0155145. PubMed ID: 27163153
[TBL] [Abstract][Full Text] [Related]
2. Estrogen/Progesterone Receptor Expression and Cancer Antigen 125 Level as Preoperative Predictors to Estimate Lymph Node Metastasis in Endometrioid Endometrial Cancer.
Wang SC; Wu CH; Fu HC; Ou YC; Tsai CC; Chen YY; Wang YW; Hunag SW; Huang SY; Lan J; Lin H
Int J Gynecol Pathol; 2024 Jul; 43(4):316-325. PubMed ID: 37732995
[TBL] [Abstract][Full Text] [Related]
3. Nodal infiltration in endometrial cancer: a prediction model using best subset regression.
Matsumoto YK; Himoto Y; Nishio M; Kikkawa N; Otani S; Ito K; Yamanoi K; Kato T; Fujimoto K; Kurata Y; Moribata Y; Yoshida H; Minamiguchi S; Mandai M; Kido A; Nakamoto Y
Eur Radiol; 2024 May; 34(5):3375-3384. PubMed ID: 37882835
[TBL] [Abstract][Full Text] [Related]
4. A nomogram composed of clinicopathologic features and preoperative serum tumor markers to predict lymph node metastasis in early gastric cancer patients.
Zhao LY; Yin Y; Li X; Zhu CJ; Wang YG; Chen XL; Zhang WH; Chen XZ; Yang K; Liu K; Zhang B; Chen ZX; Chen JP; Zhou ZG; Hu JK
Oncotarget; 2016 Sep; 7(37):59630-59639. PubMed ID: 27449100
[TBL] [Abstract][Full Text] [Related]
5. High BMI is significantly associated with positive progesterone receptor status and clinico-pathological markers for non-aggressive disease in endometrial cancer.
Mauland KK; Trovik J; Wik E; Raeder MB; Njølstad TS; Stefansson IM; Oyan AM; Kalland KH; Bjørge T; Akslen LA; Salvesen HB
Br J Cancer; 2011 Mar; 104(6):921-6. PubMed ID: 21343929
[TBL] [Abstract][Full Text] [Related]
6. [Postoperative lymph node metastasis status and related factors in patients with early-stage, low-risk endometrial cancer assessed by the Mayo criteria].
Shi XW; Wang DF; Zhang GN; Zhang J
Zhonghua Yi Xue Za Zhi; 2024 Mar; 104(10):736-741. PubMed ID: 38462353
[No Abstract] [Full Text] [Related]
7. Development of prediction models for lymph node metastasis in endometrioid endometrial carcinoma.
Berg HF; Ju Z; Myrvold M; Fasmer KE; Halle MK; Hoivik EA; Westin SN; Trovik J; Haldorsen IS; Mills GB; Krakstad C; Werner HMJ
Br J Cancer; 2020 Mar; 122(7):1014-1022. PubMed ID: 32037399
[TBL] [Abstract][Full Text] [Related]
8. Association between preoperative serum insulin levels and lymph node metastasis in endometrial cancer-a prospective cohort study.
Mu N; Dong M; Liu C; Wang X; Cong J; Wang L; Wang X; Lakhani I; Liu X; Hou J; Wang S; Tse G
Cancer Med; 2018 Apr; 7(4):1519-1527. PubMed ID: 29533014
[TBL] [Abstract][Full Text] [Related]
9. Preoperative evaluation and a nomogram prediction model for pelvic lymph node metastasis in endometrial cancer.
Zhang J; Wang D; Peng L; Shi X; Shi Y; Zhang G
Eur J Surg Oncol; 2024 Apr; 50(4):108230. PubMed ID: 38430704
[TBL] [Abstract][Full Text] [Related]
10. Progesterone receptor isoforms as a prognostic marker in human endometrial carcinoma.
Saito S; Ito K; Nagase S; Suzuki T; Akahira J; Okamura K; Yaegashi N; Sasano H
Cancer Sci; 2006 Dec; 97(12):1308-14. PubMed ID: 16999816
[TBL] [Abstract][Full Text] [Related]
11. The analysis of preoperative or intraoperative factors in predicting the escalation of surgical pathological staging of patients with clinical stage I endometrioid carcinoma: A retrospective clinical study.
Li N; Chen Q; Li B
Medicine (Baltimore); 2024 Mar; 103(11):e37465. PubMed ID: 38489719
[TBL] [Abstract][Full Text] [Related]
12. A clinical marker-based modeling framework to preoperatively predict lymph node and vascular space involvement in endometrial cancer patients.
Miller HA; Tran A; LyBarger KS; Frieboes HB
Eur J Surg Oncol; 2024 Jan; 50(1):107309. PubMed ID: 38056021
[TBL] [Abstract][Full Text] [Related]
13. Predictive models for lymph node metastasis in endometrial cancer: A systematic review and bibliometric analysis.
Li H; Wang J; Zhang G; Li L; Shen Z; Zhai Z; Wang Z; Wang J
Womens Health (Lond); 2024; 20():17455057241248398. PubMed ID: 38725247
[TBL] [Abstract][Full Text] [Related]
14. Stratification of endometrioid endometrial cancer patients into risk levels using somatic mutations.
Dai D; Thiel KW; Salinas EA; Goodheart MJ; Leslie KK; Gonzalez Bosquet J
Gynecol Oncol; 2016 Jul; 142(1):150-157. PubMed ID: 27181389
[TBL] [Abstract][Full Text] [Related]
15. Predicting lymph node metastasis in colorectal cancer: An analysis of influencing factors to develop a risk model.
Lei YP; Song QZ; Liu S; Xie JY; Lv GQ
World J Gastrointest Surg; 2023 Oct; 15(10):2234-2246. PubMed ID: 37969707
[TBL] [Abstract][Full Text] [Related]
16. Effects of coagulation function indicators and tumor markers on diagnosis and clinicopathological characteristics of endometrial cancer.
Li H; Liao H; Jing B; Wang Y
Int J Biol Markers; 2023 Dec; 38(3-4):214-222. PubMed ID: 37635376
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of prediction model for early warning of ovarian metastasis risk of endometrial carcinoma.
Zhao Q; Li Y; Wang T
Medicine (Baltimore); 2023 Oct; 102(41):e35439. PubMed ID: 37832099
[TBL] [Abstract][Full Text] [Related]
18. Molecular profile in endometrial carcinoma: can we predict the lymph node status? A systematic review and meta-analysis.
Luzarraga Aznar A; Bebia V; Gomez-Hidalgo NR; López-Gil C; Miguez M; Colas E; Pérez-Benavente A; Gil-Moreno A; Cabrera S
Clin Transl Oncol; 2024 Jul; 26(7):1768-1778. PubMed ID: 38578538
[TBL] [Abstract][Full Text] [Related]
19. Development and Validation of a 3D Resnet Model for Prediction of Lymph Node Metastasis in Head and Neck Cancer Patients.
Lin YH; Lin CT; Chang YH; Lin YY; Chen JJ; Huang CR; Hsu YW; You WC
J Imaging Inform Med; 2024 Apr; 37(2):679-687. PubMed ID: 38343258
[TBL] [Abstract][Full Text] [Related]
20. Correlation between the Expression of VEGF and Ki67 and Lymph Node Metastasis in Non-small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.
Wei D; Xin Y; Rong Y; Hao Y
Evid Based Complement Alternat Med; 2022; 2022():9693746. PubMed ID: 35800006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
